Knockout and rescue experiments indicated that FEZF1-AS1 inhibited colon cancer cell proliferation, invasion, and migration, partially dependent on PCK2, by disturbing the homeostasis of energy metabolism of the mitochondria. Here, PCK2 is linked to colonic neoplasm.